Clinical significance and prognostic value of Nek2 protein expression in colon cancer
- PMID: 26823916
- PMCID: PMC4713702
Clinical significance and prognostic value of Nek2 protein expression in colon cancer
Abstract
Objective: To determine the expression of NIMA-related kinase NEK2 and evaluate its clinical value in colon cancer.
Method: Sixty specimens of colon cancer, 30 specimens of paracancerous colon tissues and 10 specimens of normal colon tissues conventionally resected in surgery at the Second Affiliated Hospital of Nantong University from February 2006 to February 2014 were collected. These tissues were detected for the expression of Nek2 using Western Blot and immunohistochemical staining. The relationship between Nek2 protein expression and the clinicopathology and prognosis of colon tissues was discussed.
Results: The expression level and positive expression rate of Nek2 protein in the colon cancer were obviously higher than that in the paracancerous tissues and normal colon tissues. They were also significantly higher in the paracancerous tissues than in the normal tissues (P<0.05). Statistical analysis revealed that Nek2 protein expression was not obviously correlated with gender, age and tumor size, but obviously correlated with degree of differentiation (P=0.008), TNM staging (P=0.000), lymph node metastasis (P=0.022) and tumor invasion (P=0.011). With the plotting of Kaplan-Meier survival curve, it could be seen that Nek2 protein expression was not significantly correlated with survival (P=0.0048). High Nek2 protein expression may be an independent risk factor for colon cancer (HR=0.227, 95% CI 0.101-0.510).
Conclusion: High Nek2 protein expression reflects the malignant behavior of colon cancer. Playing important roles in the occurrence of colon cancer, Nek2 protein expression has diagnostic and prognostic value in colon cancer.
Keywords: Colon cancer; Nek2; expression; prognosis.
Figures



Similar articles
-
High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.Anticancer Res. 2016 Feb;36(2):757-62. Anticancer Res. 2016. PMID: 26851035
-
Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2462-9. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966957 Free PMC article.
-
Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18. Ann Surg Oncol. 2014. PMID: 24046120
-
NEK2 Is an Effective Target for Cancer Therapy With Potential to Induce Regression of Multiple Human Malignancies.Anticancer Res. 2019 May;39(5):2251-2258. doi: 10.21873/anticanres.13341. Anticancer Res. 2019. PMID: 31092416 Review.
-
One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment.Biochim Biophys Acta Rev Cancer. 2022 Mar;1877(2):188696. doi: 10.1016/j.bbcan.2022.188696. Epub 2022 Feb 12. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35157980 Review.
Cited by
-
MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.Thorac Cancer. 2017 Jul;8(4):304-311. doi: 10.1111/1759-7714.12442. Epub 2017 May 17. Thorac Cancer. 2017. PMID: 28514100 Free PMC article.
-
New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses.Sci Rep. 2024 Apr 16;14(1):8762. doi: 10.1038/s41598-024-59101-8. Sci Rep. 2024. PMID: 38627442 Free PMC article.
-
Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma.J Neurooncol. 2017 May;132(3):409-417. doi: 10.1007/s11060-017-2401-4. Epub 2017 Mar 21. J Neurooncol. 2017. PMID: 28321704
-
NEK2 promotes cancer cell progression and 5-fluorouracil resistance via the Wnt/β-catenin signaling pathway in colorectal cancer.Discov Oncol. 2025 Mar 28;16(1):417. doi: 10.1007/s12672-025-02154-6. Discov Oncol. 2025. PMID: 40153115 Free PMC article.
-
Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.J Mol Histol. 2021 Aug;52(4):809-821. doi: 10.1007/s10735-021-09979-9. Epub 2021 May 19. J Mol Histol. 2021. PMID: 34009515
References
-
- Van Cutsem E, Costa F. Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice? JAMA. 2005;294:2758–2760. - PubMed
-
- Sabbagh C, Cosse C, Chauffert B, Nguyen-Khac E, Joly JP, Yzet T, Regimbeau JM. Management of colon cancer in patients with cirrhosis: A review. Surg Oncol. 2015;24:187–93. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous